COR vs EW · P/E 21, rev $321.33B vs P/E 47, rev $1.39B
Cencora Inc. (COR) versus Edwards Lifesciences Corp (EW) — a side-by-side from cached financials, not a winner call.
Cencora Inc. (COR) is a medical distribution company listed on NYSE.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
Latest reported COR revenue for 2025-09-30 was $321.33B. Net income was $1.57B. Revenue was up 9.3% from 2024-09-30 to 2025-09-30. COR currently screens at market cap $53.91B and trailing P/E 21.2.
Latest reported EW revenue for 2024-12-31 was $1.39B. Net income was $385.6M. Revenue was up 2.3% from 2024-09-30 to 2024-12-31. EW currently screens at market cap $49.91B and trailing P/E 46.9.
COR currently screens at market cap $53.91B and trailing P/E 21.2. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Not investment advice. Open the COR and EW stock pages for the full models.
Not investment advice.